亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

鹽酸去甲基金霉素 CAS: 64-73-3

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 湖北隨州市付款后3天內(nèi)
型號(hào) 64-73-3
過(guò)期 長(zhǎng)期有效
更新 2023-06-07 15:00
 

隨州天豐化工科技有限公司

企業(yè)會(huì)員第15年
資料未認(rèn)證
保證金未繳納
詳細(xì)說(shuō)明

鹽酸去甲基金霉素
CAS: 64-73-3
分子量: 501.32 
EC NO: 200-592-2
分子式: C21H21ClN2O8·HCl
InChI: InChI=1/C21H21ClN2O8.ClH/c1-24(2)14-7-5-6-10(16(27)12-9(25)4-3-8(22)11(12)15(6)26)18(29)21(7,32)19(30)13(17(14)28)20(23)31;/h3-4,6-7,14-15,25-26,28-29,32H,5H2,1-2H3,(H2,23,31);1H/t6-,7-,14-,15-,21-;/m0./s1
別名: 去甲基金霉素;7-氯-4-二甲氨基-3,6,10,12,12a-五羥基-1,11-二氧代-1,4,4a,5,5a,6,11,12a-八氫-2-并四苯甲酰胺鹽酸鹽;鹽酸地美環(huán)素;地美環(huán)素鹽酸鹽;脫甲氯四環(huán)素;地美環(huán)素;鹽酸去甲基金霉素
含量:89-102%
標(biāo)準(zhǔn):企標(biāo)
性狀:黃色粉末


 


用途:去甲金霉素抗菌活性較四環(huán)素強(qiáng),吸收較好。是廣譜抗生素,起抑菌作用。其抗菌譜包括許多革蘭陽(yáng)性和陰性菌、立克次體、支原體、衣原體、放線菌等。現(xiàn)主要用于立克次體病、布氏桿菌病、淋巴肉芽腫、支原體肺炎、螺旋體病、衣原體病,也可用于敏感的革蘭陽(yáng)性球菌或革蘭陰性桿菌所引起的輕癥感染。
包裝:25KG/桶

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
新魚(yú)腥草素鈉 鹽酸洛哌丁胺CAS 34552-83-5 度米芬 CAS號(hào): 538-71-6 對(duì)甲苯磺酸甲酯 胞磷膽堿鈉 CAS號(hào): 33818-15-4 加替沙星CAS號(hào): 112811-59-3 馬來(lái)酸曲美布汀CAS號(hào): 34140-59-5
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |